We are a world-leading cancer research institute, a charity, and a member institution of the University of London. Public donations and clinical partnerships are helping us to make the discoveries ...

Our multidisciplinary centres of excellence and strategic collaborations bring a critical mass of leading researchers together from across the ICR, The Royal Marsden and partner institutions to tackle ...

Our academic clinicians bring knowledge of clinical practice into the lab and take laboratory research back into the clinic ...

We offer approximately 20 fully funded PhD studentships each year. Our main round opens in October, but we also advertise projects throughout the year. We provide a generous stipend and cover tuition ...

Professor Chris Bakal’s group uses genomic approaches and computational modelling to understand how complex biochemical signalling networks are ‘rewired’ during the development of cancer. Our goal is ...

We provide exceptional opportunities for the best scientists, clinicians, and professional and administrative staff, and excellent academic and recreational facilities at our two London sites, in ...

Established in 2007, the NIHR BRC funds and supports innovative translational research, meaning that it takes leading-edge cancer research from the laboratory and rapidly translates it into clinical ...

We are a world-leading cancer research institute, a charity, and a member institution of the University of London. Public donations and clinical partnerships are helping us to make the discoveries ...

Clinical trials are the single best way to turn advances in science into patient benefits. The ICR has a vision that a suitable trial should be made available for every person with cancer who wants to ...

We applied the principle of synthetic lethality to discover a novel strategy for cancer treatment for patients with BRCA1 or BRCA2 gene mutations. We demonstrated that drugs called PARP inhibitors ...

Professor Kamil R Kranc graduated in medicine from the Medical University of Silesia (Poland) in 2000. He then moved to the University of Oxford to obtain a DPhil in Biochemistry in 2003, followed by ...

With The Royal Marsden we work across several centres to take the results of our research rapidly into the clinic to develop better treatments for cancer patients. We’ve developed collaborations with ...